Garcia-Retamero R, Cokely ET, Ghazal S, Joeris A Measuring Graph Literacy without a Test: A Brief Subjective Assessment. Med Decis Making. 2016 Oct;36(7):854-67. doi: 10.1177/0272989X16655334. Epub 2016 Jun 27.
Garcia-Retamero R, Galesic M, Gigerenzer G Enhancing understanding and recall of quantitative information about medical risks: a cross-cultural comparison between Germany and Spain. Span J Psychol. 2011 May;14(1):218-26.
Gigerenzer G, Wegwarth O Five year survival rates can mislead. BMJ. 2013 Jan 29;346:f548. doi: 10.1136/bmj.f548. Review.
Jenny MA, Keller N, Gigerenzer G Assessing minimal medical statistical literacy using the Quick Risk Test: a prospective observational study in Germany. BMJ Open. 2018 Aug 23;8(8):e020847. doi: 10.1136/bmjopen-2017-020847. Erratum in: BMJ Open. 2018 Oct 18;8(10):e020847corr2.
Keller N, Feufel MA, Kendel F, Spies CD, Gigerenzer G Training medical students how to extract, assess and communicate evidence from an article. Med Educ. 2017 Nov;51(11):1162-1163. doi: 10.1111/medu.13444. Epub 2017 Sep 7.
Lindskog M, Kerimi N, Winman A, Juslin P A Swedish validation of the Berlin Numeracy Test. Scand J Psychol. 2015 Apr;56(2):132-9. doi: 10.1111/sjop.12189. Epub 2015 Jan 8.
Wegwarth O, Wagner GG, Gigerenzer G Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations. PLoS One. 2017 Aug 23;12(8):e0183024. doi: 10.1371/journal.pone.0183024. eCollection 2017.
Risk Literacy Among Portuguese Medical and Dentistry Students - a Cohort Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.